News

Pfizer: Better To Face The Harsh Reality Than Continue Waiting
Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...
BioSpace8d
After FDA Cuts, Planning for Upcoming ODAC Meeting Has Been ‘Absolute Chaos’
As the FDA prepares for a busy Oncologic Drugs Advisory Committee meeting next week, an agency insider told BioSpace that ...
Makary’s FDA funding ask
FDA Commissioner Marty Makary was met with a skeptical set of Senate appropriators Thursday when he testified on his agency’s ...
Daily Times on MSN7d
FDA approves Novavax covid vaccine with limits on eligibility
The US Food and Drug Administration (FDA) has approved Novavax's Covid-19 vaccine, Nuvaxovid, but only for limited use in ...
Devdiscourse7d
FDA Grants Conditional Approval to Novavax's COVID-19 Vaccine
The U.S. FDA approved Novavax's COVID-19 vaccine with conditions, allowing use for people 65 and older and those 12-64 with ...
FDA Approves New Covid Vaccine
The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
KSL6d
Novavax shares jump after long-awaited FDA approval of COVID-19 vaccine
Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine, ...
FDA approves Novavax COVID vaccine with new conditions
According to the approval letter, the license restricts the use of the vaccine called Nuvaxovid to individuals aged 65 and ...